PMGC Holdings Inc. (Nasdaq: ELAB) Secures Five-Year Royalty Stream from Elevai Skincare Sale Under Executed Payment Agreement with Longevity Health Holdings
PMGC Holdings (Nasdaq: ELAB) executed a binding payment agreement with Longevity Health Holdings that converts the 5% net sales royalty from its January 2025 Elevai Skincare divestiture into scheduled, interest-bearing cash payments running through August 2031. Longevity acknowledged owing $94,937 for the 2025 royalty, accruing interest at the WSJ Prime Rate plus 1.00% from the original April 2026 due date, with $10,000 monthly installments beginning October 15, 2026.
Key figures
- Royalty rate
- 5% of net sales
- Interest rate
- WSJ Prime Rate + 1.00% per annum
- Final due date
- August 28, 2031
- Payment start date
- October 15, 2026
- Monthly installment
- 10000
- Acknowledged 2025 royalty
- 94937
- Mandatory prepayment rate
- 15%
- Mandatory prepayment threshold
- 350000
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.